Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · page 10 of 56
The slide uses a visual representation of an antibody molecule with callouts to specific engineering improvements, supported by a scatter plot showing clinical precedent for half-life extension.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 8/8
chart 1/1 image 1/1 list 4/4 title 2/2
Components 8
scatter illustration bullet bullet bullet bullet action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1